BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//ACC//Meetings//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011101T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD BEGIN:DAYLIGHT DTSTART:16010301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\nWebinar Overview\n\nThis webinar explores the significanc e of Lp(a) and risk for cardiovascular disease. Discussion topics include the approaches to cardiovascular risk assessment\, how to treat elevated L p(a)\, and new therapies on the horizon for this condition. Primary and se condary prevention cases will be discussed and open to our audience for di scussion with faculty. This activity is part of the Elevating Lp(a) Awaren ess: Bridging the CVD Risk Knowledge Gap grant with support from Novartis. \n\nKey Objectives/Learning Outcomes:\n\nDefine key terminology related to Lp(a) and atherosclerotic cardiovascular disease (ASCVD). \nReview the un ique role of Lp(a) as a genetic determinant for ASCVD risk and special con siderations including high risk racial and gender groups. \nRecognize the specific importance of Lp(a) levels and testing in cardiovascular health f rom general lipids.\n\n\nWebinar Recording\n\n\n-->\n\nWebinar Participant s\nErin D. Michos\, MD\, FACC\nChristie M. Ballantyne\, MD\, FACC\nGissett e Reyes Soffer\, MD\nSusan Halli-Demeter\, DNP\, CNP\, NP\nSteven E. Nisse n\, MD\, MACC\n\nCredit Information\nThe credit offered for this 1-hour we binar has been confirmed as follows:\n1 CME\n1 MOC\n1 CNE\n1 AAPA\n1 IPCE\ n\n\n\n\n\n .videoWrapper {\n position: relative\;\n padding-bott om: 56.25%\; /* 16:9 */\n padding-top: 25px\;\n height: 0\;\n }\n .videoWrapper iframe {\n position: absolute\;\n top: 0\;\n le ft: 0\;\n width: 100%\;\n height: 100%\;\n }\n\n DTEND;TZID=Eastern Standard Time:20241107T141500 DTSTAMP:20260409T210338Z DTSTART;TZID=Eastern Standard Time:20241107T140000 LOCATION:Online - Eastern Time (ET) SEQUENCE:0 SUMMARY:Lp(a): What You Can Do Now — Current Insights and Future Directions in Cardiovascular Health UID:978b7675-7010-42c8-91f0-afaeac300ed2@acc.org X-ALT-DESC;FMTTYPE=text/html:
\n
\n\n

Webinar Overvi ew

\n\n

This webinar explores the significanc e of Lp(a) and risk for cardiovascular disease. Discussion topics include the approaches to cardiovascular risk assessment\, how to treat elevated L p(a)\, and new therapies on the horizon for this condition. Primary and se condary prevention cases will be discussed and open to our audience for di scussion with faculty. This activity is part of the Elevati ng Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap grant with sup port from Novartis.

\n\n

Key Objectives/Learni ng Outcomes:

\n
    \n
  1. Define key terminology related to Lp(a) and atherosclerotic cardiovascular disease (ASCVD).
    2. \n
  2. Review the unique role of Lp(a) as a genetic determinant for ASCVD risk and special considerations including high risk racial and gender grou ps.
    3. \n
  3. Recognize the specific importance of Lp(a) levels and testi ng in cardiovascular health from general lipids.
    4. \n
\n\n\n\n

Webinar Pa rticipants

\n

Erin D. Michos\, MD\, FACC
\nChristie M. Ba llantyne\, MD\, FACC
\nGissette Reyes Soffer\, MD
\nSusan Halli-Deme ter\, DNP\, CNP\, NP
\nSteven E. Nissen\, MD\, MACC

\n\n

Credit Information

\n

The credit offered for t his 1-hour webinar has been confirmed as follows:
\n1 CME
\n1 MOC
\n1 CNE
\n1 AAPA
\n1 IPCE

\n\n
\n\n
\n\n BEGIN:VALARM ACTION:Display DESCRIPTION:Reminder TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR